Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Capitalization 197B P/E ratio 2024 *
33.8x
P/E ratio 2025 * 28.9x
Enterprise value 203B EV / Sales 2024 *
4.85x
EV / Sales 2025 * 4.46x
Free-Float
86.97%
Yield 2024 *
1.96%
Yield 2025 * 2.11%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.14%
1 week+0.30%
Current month-0.15%
1 month+4.11%
3 months+9.56%
6 months-4.54%
Current year+2.75%
More quotes
1 week
112.52
Extreme 112.52
115.59
1 month
107.11
Extreme 107.105
115.59
Current year
99.71
Extreme 99.71
121.64
1 year
89.67
Extreme 89.674
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Director TitleAgeSince
Chief Executive Officer 50 14-12-31
Director of Finance/CFO 51 96-12-31
Chief Tech/Sci/R&D Officer - 89-12-31
Manager TitleAgeSince
Director/Board Member 73 08-10-09
Director/Board Member 62 11-12-08
Director/Board Member 65 11-12-08
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.14%+0.30%+12.11%-12.28%197B
-1.80%+1.36%+11.46%-33.60%115B
-1.31%-3.20%-14.52%-9.53%67.42B
-2.94%-0.57%+36.66%+88.78%46.3B
-0.42%-7.02%+15.15%+6.51%46.57B
-0.08%-3.12%+14.03%-11.98%29.42B
-1.10%-0.82%-31.18%-49.08%27.67B
+0.04%-1.62%+20.99%+5.00%27.34B
-0.57%+0.56%+6.89%+9.75%23.57B
-8.74%-8.90%-11.32%-28.81%21.28B
Average -1.81%-2.60%+6.03%-3.53% 60.1B
Weighted average by Cap. -1.51%-1.29%+8.60%-7.41%
See all sector performances
2024 *2025 *
Net sales 41.74B 44.77B
Net income 5.81B 6.83B
Net Debt 5.85B 2.69B
More financial data * Estimated data
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Employees
114,000
Related indices
More about the company
Date Price Change Volume
24-09-05 113.10 $ -1.14% 2,928,009
24-09-04 114.40 $ -0.23% 3,659,202
24-09-03 114.66 $ +1.23% 4,436,991
24-08-30 113.27 $ +0.45% 4,320,139
24-08-29 112.76 $ -0.12% 3,375,767

Delayed Quote Nyse, September 05, 2024 at 04:00 pm EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
113.10USD
Average target price
124.28USD
Spread / Average Target
+9.89%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW